You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 4
  • 392 Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: subgroup analysis by risk in the phase III solo1 study

Article metrics

Article menu

Download PDFPDF

Ovarian cancer
392 Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: subgroup analysis by risk in the phase III solo1 study
Free

 

Online download statistics by month:

Online download statistics by month: December 2020 to March 2023

AbstractFullPdf
Dec 202089021
Jan 202161015
Feb 202173020
Mar 202164015
Apr 202166022
May 202133019
Jun 20210014
Jul 2021009
Aug 2021008
Sep 2021007
Oct 202150028
Nov 202184025
Dec 202174014
Jan 20224404
Feb 20224803
Mar 20226803
Apr 20227208
May 202288016
Jun 20228908
Jul 20228206
Aug 202280014
Sep 2022148019
Oct 202296017
Nov 20227408
Dec 202250013
Jan 202380011
Feb 2023126013
Mar 20239607
Total18350367